Published in Pediatr Infect Dis J on October 01, 2013
Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review. J Int AIDS Soc (2015) 0.90
Neurodevelopmental benefits of antiretroviral therapy in Ugandan children aged 0-6 years with HIV. J Acquir Immune Defic Syndr (2014) 0.85
Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age. Pediatr Infect Dis J (2014) 0.80
Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir Exposure. J Acquir Immune Defic Syndr (2015) 0.80
Atazanavir exposure in utero and neurodevelopment in infants: a comparative safety study. AIDS (2016) 0.79
Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States. AIDS Res Hum Retroviruses (2016) 0.78
Correlates of age at attainment of developmental milestones in HIV-infected infants receiving early antiretroviral therapy. Pediatr Infect Dis J (2015) 0.77
Preventing and managing HIV infection in infants, children, and adolescents in the United States. Pediatr Rev (2014) 0.76
The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs. Front Immunol (2016) 0.76
Developmental delay and behavioral disorders in 59 HIV-exposed uninfected infants. Transl Pediatr (2017) 0.75
Risk factors affecting child cognitive development: a summary of nutrition, environment, and maternal-child interaction indicators for sub-Saharan Africa. J Dev Orig Health Dis (2015) 0.75
Auditory Alterations in Children Infected by Human Immunodeficiency Virus Verified Through Auditory Processing Test. Int Arch Otorhinolaryngol (2016) 0.75
Newborn Hearing Screenings in Human Immunodeficiency Virus-Exposed Uninfected Infants. J AIDS Immune Res (2016) 0.75
Antiretroviral Treatment in HIV-1-Positive Mothers: Neurological Implications in Virus-Free Children. Int J Mol Sci (2017) 0.75
Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months. Pediatrics (2017) 0.75
An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics (2004) 2.80
Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy. J Infect Dis (2011) 2.42
On the pitfalls of adjusting for gestational age at birth. Am J Epidemiol (2011) 2.29
Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med (2006) 2.19
Neuropsychological comparison of alcohol-exposed children with or without physical features of fetal alcohol syndrome. Neuropsychology (1998) 2.03
Bilirubin induces apoptosis via the mitochondrial pathway in developing rat brain neurons. Hepatology (2002) 1.96
Late language emergence at 24 months: an epidemiological study of prevalence, predictors, and covariates. J Speech Lang Hear Res (2007) 1.84
Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? Clin Infect Dis (2012) 1.80
Outcomes in a population of healthy term and near-term infants with serum bilirubin levels of >or=325 micromol/L (>or=19 mg/dL) who were born in Nova Scotia, Canada, between 1994 and 2000. Pediatrics (2008) 1.61
Measurement properties of the MacArthur communicative development inventories at ages one and two years. Child Dev (2000) 1.57
Bilirubin induces apoptosis and necrosis in human NT2-N neurons. Pediatr Res (2004) 1.49
Neurodevelopment in children born to HIV-infected mothers by infection and treatment status. Pediatrics (2012) 1.40
Early term and late preterm birth are associated with poorer school performance at age 5 years: a cohort study. Arch Dis Child Fetal Neonatal Ed (2012) 1.35
In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States. AIDS Patient Care STDS (2011) 1.26
Substance use in HIV-Infected women during pregnancy: self-report versus meconium analysis. AIDS Behav (2010) 1.26
A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothers. Am J Epidemiol (2012) 1.17
Language impairment in children perinatally infected with HIV compared to children who were HIV-exposed and uninfected. J Dev Behav Pediatr (2012) 1.08
Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants. Pediatr Infect Dis J (2013) 1.05
Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women. HIV Med (2011) 1.01
Atazanavir in pregnancy: impact on neonatal hyperbilirubinemia. Eur J Obstet Gynecol Reprod Biol (2011) 1.00
Language functions in preterm-born children: a systematic review and meta-analysis. Pediatrics (2012) 1.00
Epigenetic modifications may play a role in the developmental consequences of early life events. J Neurodev Disord (2011) 0.89
Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol (2007) 7.06
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Health behavior models in the age of mobile interventions: are our theories up to the task? Transl Behav Med (2011) 6.46
Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ (2013) 3.88
Diabetes and hearing impairment in the United States: audiometric evidence from the National Health and Nutrition Examination Survey, 1999 to 2004. Ann Intern Med (2008) 3.70
Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis (2008) 3.09
Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr (2010) 2.96
Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA (2006) 2.96
Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples. Environ Health Perspect (2008) 2.75
Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis (2004) 2.70
Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics (2006) 2.62
Variability of urinary phthalate metabolite and bisphenol A concentrations before and during pregnancy. Environ Health Perspect (2012) 2.43
Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort. Pediatrics (2003) 2.36
Polymorphisms in the mannose binding lectin-2 gene and acute respiratory distress syndrome. Crit Care Med (2007) 2.31
Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection. Annu Rev Med (2010) 2.28
Trends in infant bed sharing in the United States, 1993-2000: the National Infant Sleep Position study. Arch Pediatr Adolesc Med (2003) 2.24
Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants. AIDS (2012) 2.19
Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS (2009) 2.16
An application of propensity score matching using claims data. Pharmacoepidemiol Drug Saf (2005) 2.15
Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. J Infect Dis (2003) 2.04
Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States. J Infect Dis (2007) 1.96
Predictors and variability of urinary paraben concentrations in men and women, including before and during pregnancy. Environ Health Perspect (2012) 1.96
Preexposure prophylaxis for adolescents and young adults at risk for HIV infection: is an ounce of prevention worth a pound of cure? Clin Infect Dis (2012) 1.86
Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report. Pediatrics (2012) 1.85
Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads. J Virol (2004) 1.85
Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection. Pediatrics (2009) 1.79
Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations. PLoS One (2013) 1.74
Patient-, provider-, and clinic-level predictors of unrecognized elevated blood pressure in children. Pediatrics (2010) 1.73
The association of particulate air metal concentrations with heart rate variability. Environ Health Perspect (2002) 1.71
Behavioral health risks in perinatally HIV-exposed youth: co-occurrence of sexual and drug use behavior, mental health problems, and nonadherence to antiretroviral treatment. AIDS Patient Care STDS (2011) 1.66
Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy. AIDS Res Hum Retroviruses (2007) 1.63
Antiretroviral treatment strategies in highly treatment experienced perinatally HIV-infected youth. Pediatr Infect Dis J (2012) 1.62
Serum concentrations of polychlorinated biphenyls in relation to in vitro fertilization outcomes. Environ Health Perspect (2011) 1.60
Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting. Clin Infect Dis (2008) 1.60
Gender differences in health-related quality of life in patients with HIV/AIDS. Qual Life Res (2005) 1.60
Randomized controlled trial of cephalexin versus clindamycin for uncomplicated pediatric skin infections. Pediatrics (2011) 1.58
NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of fluoxetine. Birth Defects Res B Dev Reprod Toxicol (2004) 1.57
Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes. J Acquir Immune Defic Syndr (2011) 1.55
Long-term follow-up of HIV-infected individuals who have significant increases in CD4+ cell counts during antiretroviral therapy. Clin Infect Dis (2004) 1.54
Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol (2005) 1.53
Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection. Pediatrics (2004) 1.51
Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposure. AIDS Care (2011) 1.51
Urinary bisphenol A concentrations and early reproductive health outcomes among women undergoing IVF. Hum Reprod (2012) 1.48
Maternal urinary metabolites of Di-(2-Ethylhexyl) phthalate in relation to the timing of labor in a US multicenter pregnancy cohort study. Am J Epidemiol (2009) 1.47
Nosocomial rotavirus infections: a systematic review. J Pediatr (2006) 1.45
Trends in antiretroviral therapy use and survival rates for a large cohort of HIV-infected children and adolescents in the United States, 1989-2001. J Acquir Immune Defic Syndr (2005) 1.44
Effects of perinatal HIV infection and associated risk factors on cognitive development among young children. Pediatrics (2006) 1.43
Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus. J Infect Dis (2010) 1.42
Challenges in using observational studies to evaluate adverse effects of treatment. N Engl J Med (2007) 1.42
Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence. Pediatr Infect Dis J (2012) 1.41
The contribution of prone sleeping position to the racial disparity in sudden infant death syndrome: the Chicago Infant Mortality Study. Pediatrics (2002) 1.41
Genetic modification of the association between peripubertal dioxin exposure and pubertal onset in a cohort of Russian boys. Environ Health Perspect (2012) 1.39
The association between personal measurements of environmental exposure to particulates and heart rate variability. Epidemiology (2002) 1.38
Use of a dummy (pacifier) during sleep and risk of sudden infant death syndrome (SIDS): population based case-control study. BMJ (2005) 1.37
Co-occuring psychiatric symptoms in children perinatally infected with HIV and peer comparison sample. J Dev Behav Pediatr (2010) 1.36
Urinary bisphenol A concentrations and implantation failure among women undergoing in vitro fertilization. Environ Health Perspect (2012) 1.34
Impairments in hearing and vision impact on mortality in older people: the AGES-Reykjavik Study. Age Ageing (2013) 1.32
Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells. J Infect Dis (2006) 1.32
A mechanistic role for type III IFN-λ1 in asthma exacerbations mediated by human rhinoviruses. Am J Respir Crit Care Med (2011) 1.31
Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C. Pediatr Infect Dis J (2010) 1.31
The role of cognitive functioning in medication adherence of children and adolescents with HIV infection. J Pediatr Psychol (2008) 1.30
A propensity score-matched cohort study of the effect of statins, mainly fluvastatin, on the occurrence of acute myocardial infarction. Am J Cardiol (2003) 1.29
In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States. AIDS Patient Care STDS (2011) 1.26
Sexual risk behavior among youth with perinatal HIV infection in the United States: predictors and implications for intervention development. Clin Infect Dis (2012) 1.26
Screened and unscreened hearing threshold levels for the adult population: results from the Nord-Trøndelag Hearing Loss Study. Int J Audiol (2005) 1.26
HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS (2007) 1.25
Combination antiretroviral use and preterm birth. J Infect Dis (2012) 1.25
Allocation of family responsibility for illness management in pediatric HIV. J Pediatr Psychol (2008) 1.24
Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants. Pediatrics (2010) 1.22
Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents. Pediatrics (2009) 1.22
Norming plans for the NIH Toolbox. Neurology (2013) 1.20
Longitudinal study of emerging mental health concerns in youth perinatally infected with HIV and peer comparisons. J Dev Behav Pediatr (2012) 1.20
Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol Teratol (2007) 1.19
Epidemiology, natural history, and risk factors: panel report from the Ninth International Research Conference on Otitis Media. Int J Pediatr Otorhinolaryngol (2009) 1.18
Correlates of perinatal depression in HIV-infected women. AIDS Patient Care STDS (2009) 1.18
Assessment of adherence to antiretroviral therapy in perinatally HIV-infected children and youth using self-report measures and pill count. J Dev Behav Pediatr (2008) 1.18
A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothers. Am J Epidemiol (2012) 1.17
Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era. Arch Pediatr Adolesc Med (2009) 1.16
Maternal periodontitis and adverse pregnancy outcomes. Community Dent Oral Epidemiol (2008) 1.15
Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children. HIV Med (2011) 1.14
Medication adherence in children and adolescents with HIV infection: associations with behavioral impairment. AIDS Patient Care STDS (2011) 1.14
Hearing loss induced by noise, ear infections, and head injuries: results from the Nord-Trøndelag Hearing Loss Study. Int J Audiol (2003) 1.14
Tenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infection. Pediatr Infect Dis J (2013) 1.14
Bone mineral density in children and adolescents with perinatal HIV infection. AIDS (2013) 1.13
Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362. AIDS Care (2011) 1.13
Sleep position of low birth weight infants. Pediatrics (2003) 1.12